Literature DB >> 11785276

Finasteride. Does it affect spermatogenesis and pregnancy?

M Pole1, G Koren.   

Abstract

QUESTION: A few women have asked me whether finasteride, taken by their partners for male pattern baldness, will affect their pregnancies. The product monograph is very alarming: it sounds as if even handling the medication could cause harm, especially to a male fetus. Should a man stop taking finasteride if his partner is planning pregnancy or is pregnant? What is the risk to the fetus if its mother accidentally handles crushed or broken tablets? ANSWER: To date, there are no reports of adverse pregnancy outcomes among women exposed to finasteride. Taking 1 mg of finasteride daily did not have any clinically significant effect on men's semen. Absorption through the skin while handling tablets is extremely unlikely to cause fetal exposure or harm. There is no reason to discontinue the drug. Motherisk is currently following up women who are pregnant or planning pregnancy and whose partners are taking finasteride.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11785276      PMCID: PMC2018472     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  10 in total

Review 1.  Finasteride--an update and review.

Authors:  J C Cather; D Lane; M R Heaphy; B R Nelson
Journal:  Cutis       Date:  1999-09

2.  Paternity by intrauterine insemination with sperm from a man with 5alpha-reductase-2 deficiency.

Authors:  M D Katz; I Kligman; L Q Cai; Y S Zhu; C M Fratianni; I Zervoudakis; Z Rosenwaks; J Imperato-McGinley
Journal:  N Engl J Med       Date:  1997-04-03       Impact factor: 91.245

Review 3.  5 alpha-reductase inhibitors--a new hope in dermatology?

Authors:  B Amichai; M H Grunwald; R Sobel
Journal:  Int J Dermatol       Date:  1997-03       Impact factor: 2.736

4.  Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias.

Authors:  P C Walsh; J D Madden; M J Harrod; J L Goldstein; P C MacDonald; J D Wilson
Journal:  N Engl J Med       Date:  1974-10-31       Impact factor: 91.245

5.  Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men.

Authors:  J W Overstreet; V L Fuh; J Gould; S S Howards; M M Lieber; W Hellstrom; S Shapiro; P Carroll; R S Corfman; S Petrou; R Lewis; P Toth; T Shown; J Roy; J P Jarow; J Bonilla; C A Jacobsen; D Z Wang; K D Kaufman
Journal:  J Urol       Date:  1999-10       Impact factor: 7.450

6.  Clinical and hormonal effects of the 5 alpha-reductase inhibitor finasteride in idiopathic hirsutism.

Authors:  P Moghetti; R Castello; C M Magnani; F Tosi; C Negri; D Armanini; G Bellotti; M Muggeo
Journal:  J Clin Endocrinol Metab       Date:  1994-10       Impact factor: 5.958

7.  Androgen binding capacity and 5 alpha-reductase activity in pubic skin fibroblasts from hirsute patients.

Authors:  I Mowszowicz; E Melanitou; A Doukani; F Wright; F Kuttenn; P Mauvais-Jarvis
Journal:  J Clin Endocrinol Metab       Date:  1983-06       Impact factor: 5.958

8.  Male pseudohermaphroditism due to 5 alpha-reductase deficiency in a Swedish family.

Authors:  S A Ivarsson; M D Nielsen; T Lindberg
Journal:  Eur J Pediatr       Date:  1988-06       Impact factor: 3.183

9.  Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism.

Authors:  J Imperato-McGinley; L Guerrero; T Gautier; R E Peterson
Journal:  Science       Date:  1974-12-27       Impact factor: 47.728

10.  5 alpha-Reductase activity in the genital skin of hirsute women.

Authors:  P Serafini; F Ablan; R A Lobo
Journal:  J Clin Endocrinol Metab       Date:  1985-02       Impact factor: 5.958

  10 in total
  1 in total

Review 1.  Androgenetic Alopecia: An Update of Treatment Options.

Authors:  Yanna Kelly; Aline Blanco; Antonella Tosti
Journal:  Drugs       Date:  2016-09       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.